MeSH tree: D12.776.049.407
What has long been interpreted as permanent and irreversible vascular damage may not be exclusively so. In people with Down syndrome—one of the most robust populations for studying Alzheimer's disease due to the near-universal ...
Mar 19, 2026
0
6
Amyloid beta and tau proteins compete for the same binding sites on microtubules in neurons, suggesting that displacement of tau by amyloid beta, rather than aggregation of either protein, may be the primary driver of Alzheimer's ...
Mar 17, 2026
0
9
Alzheimer's disease (AD) is a neurodegenerative disease that causes progressive memory loss and a significant decline in mental functions. Past studies have shown that people with AD exhibit a buildup of a protein called ...
A team of researchers at the USC Mark and Mary Stevens Neuroimaging and Informatics Institute (Stevens INI) at the Keck School of Medicine of USC has identified important differences in how early Alzheimer's disease-related ...
Mar 12, 2026
0
12
A retinal image could help doctors quickly distinguish between similar neurodegenerative diseases, such as ALS and Alzheimer's disease, and with remarkable accuracy, according to new research published in the journal Alzheimer's ...
Mar 11, 2026
0
7
With aging populations on the rise, the need for better tools to diagnose and monitor Alzheimer's disease (AD), the most common cause of dementia, has never been more urgent. This disease is characterized by the gradual loss ...
Mar 10, 2026
0
7
Neuroscientists at King's College London have pinpointed a mechanism behind the increased neural connectivity observed in the very early stages of Alzheimer's disease. Published in Translational Psychiatry, the study also ...
Mar 9, 2026
0
13
No matter how much you brush, floss and rinse, there's a zoo colonizing your teeth, gums and tongue.
Mar 8, 2026
1
10
While companies developing drugs to treat Alzheimer's disease have spent decades and many billions of dollars targeting amyloid beta due to its role in clogging patients' brains with harmful deposits, a biochemist at the ...
Mar 2, 2026
0
46
Lithium—a decades-old treatment for bipolar disorder—may hold potential neuroprotective benefits beyond mood stabilization. An exploratory clinical trial from the University of Pittsburgh suggests that low-dose oral lithium ...
Mar 2, 2026
0
31
